These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27400756)

  • 1. Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin: Fragment-Based Drug Design Facilitated by Dynamic Combinatorial Chemistry.
    Mondal M; Radeva N; Fanlo-Virgós H; Otto S; Klebe G; Hirsch AK
    Angew Chem Int Ed Engl; 2016 Aug; 55(32):9422-6. PubMed ID: 27400756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Synthesis of Bioisosteres of Acylhydrazones as Stable Inhibitors of the Aspartic Protease Endothiapepsin.
    Jumde VR; Mondal M; Gierse RM; Unver MY; Magari F; van Lier RCW; Heine A; Klebe G; Hirsch AKH
    ChemMedChem; 2018 Nov; 13(21):2266-2270. PubMed ID: 30178575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design of inhibitors of the aspartic protease endothiapepsin by exploiting dynamic combinatorial chemistry.
    Mondal M; Radeva N; Köster H; Park A; Potamitis C; Zervou M; Klebe G; Hirsch AK
    Angew Chem Int Ed Engl; 2014 Mar; 53(12):3259-63. PubMed ID: 24532096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Optimization of Inhibitors of the Aspartic Protease Endothiapepsin.
    Hartman AM; Mondal M; Radeva N; Klebe G; Hirsch AK
    Int J Mol Sci; 2015 Aug; 16(8):19184-94. PubMed ID: 26287174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragment-Based Drug Design Facilitated by Protein-Templated Click Chemistry: Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin.
    Mondal M; Unver MY; Pal A; Bakker M; Berrier SP; Hirsch AK
    Chemistry; 2016 Oct; 22(42):14826-14830. PubMed ID: 27604032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease: identification and development of β-secretase (BACE-1) binding fragments and inhibitors by dynamic ligation screening (DLS).
    Fernández-Bachiller MI; Horatscheck A; Lisurek M; Rademann J
    ChemMedChem; 2013 Jul; 8(7):1041-56. PubMed ID: 23757181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental Active-Site Mapping by Fragments: Hot Spots Remote from the Catalytic Center of Endothiapepsin.
    Radeva N; Krimmer SG; Stieler M; Fu K; Wang X; Ehrmann FR; Metz A; Huschmann FU; Weiss MS; Mueller U; Schiebel J; Heine A; Klebe G
    J Med Chem; 2016 Aug; 59(16):7561-75. PubMed ID: 27463859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracing binding modes in hit-to-lead optimization: chameleon-like poses of aspartic protease inhibitors.
    Kuhnert M; Köster H; Bartholomäus R; Park AY; Shahim A; Heine A; Steuber H; Klebe G; Diederich WE
    Angew Chem Int Ed Engl; 2015 Feb; 54(9):2849-53. PubMed ID: 25630461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors.
    Xu YZ; Yuan S; Bowers S; Hom RK; Chan W; Sham HL; Zhu YL; Beroza P; Pan H; Brecht E; Yao N; Lougheed J; Yan J; Tam D; Ren Z; Ruslim L; Bova MP; Artis DR
    Bioorg Med Chem Lett; 2013 May; 23(10):3075-80. PubMed ID: 23570791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel approach of fragment-based lead discovery applied to renin inhibitors.
    Tawada M; Suzuki S; Imaeda Y; Oki H; Snell G; Behnke CA; Kondo M; Tarui N; Tanaka T; Kuroita T; Tomimoto M
    Bioorg Med Chem; 2016 Nov; 24(22):6066-6074. PubMed ID: 27720325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.
    Bowers S; Xu YZ; Yuan S; Probst GD; Hom RK; Chan W; Konradi AW; Sham HL; Zhu YL; Beroza P; Pan H; Brecht E; Yao N; Lougheed J; Tam D; Ren Z; Ruslim L; Bova MP; Artis DR
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2181-6. PubMed ID: 23465612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure of endothiapepsin complexed with a Phe-Tyr reduced-bond inhibitor at 1.35 Å resolution.
    Guo J; Cooper JB; Wood SP
    Acta Crystallogr F Struct Biol Commun; 2014 Jan; 70(Pt 1):30-3. PubMed ID: 24419612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A small nonrule of 3 compatible fragment library provides high hit rate of endothiapepsin crystal structures with various fragment chemotypes.
    Köster H; Craan T; Brass S; Herhaus C; Zentgraf M; Neumann L; Heine A; Klebe G
    J Med Chem; 2011 Nov; 54(22):7784-96. PubMed ID: 21972967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragment-based discovery and optimization of BACE1 inhibitors.
    Madden J; Dod JR; Godemann R; Kraemer J; Smith M; Biniszkiewicz M; Hallett DJ; Barker J; Dyekjaer JD; Hesterkamp T
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5329-33. PubMed ID: 20656487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insight into the structural similarity between HIV protease and secreted aspartic protease-2 and binding mode analysis of HIV-Candida albicans inhibitors.
    Calugi C; Guarna A; Trabocchi A
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):936-43. PubMed ID: 22803674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One Question, Multiple Answers: Biochemical and Biophysical Screening Methods Retrieve Deviating Fragment Hit Lists.
    Schiebel J; Radeva N; Köster H; Metz A; Krotzky T; Kuhnert M; Diederich WE; Heine A; Neumann L; Atmanene C; Roecklin D; Vivat-Hannah V; Renaud JP; Meinecke R; Schlinck N; Sitte A; Popp F; Zeeb M; Klebe G
    ChemMedChem; 2015 Sep; 10(9):1511-21. PubMed ID: 26259992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective progression of nuclear magnetic resonance-detected fragment hits.
    Eaton HL; Wyss DF
    Methods Enzymol; 2011; 493():447-68. PubMed ID: 21371601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six Biophysical Screening Methods Miss a Large Proportion of Crystallographically Discovered Fragment Hits: A Case Study.
    Schiebel J; Radeva N; Krimmer SG; Wang X; Stieler M; Ehrmann FR; Fu K; Metz A; Huschmann FU; Weiss MS; Mueller U; Heine A; Klebe G
    ACS Chem Biol; 2016 Jun; 11(6):1693-701. PubMed ID: 27028906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand retargeting by binding site analogy.
    Wiedmer L; Schärer C; Spiliotopoulos D; Hürzeler M; Śledź P; Caflisch A
    Eur J Med Chem; 2019 Aug; 175():107-113. PubMed ID: 31077996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors.
    Wang YS; Strickland C; Voigt JH; Kennedy ME; Beyer BM; Senior MM; Smith EM; Nechuta TL; Madison VS; Czarniecki M; McKittrick BA; Stamford AW; Parker EM; Hunter JC; Greenlee WJ; Wyss DF
    J Med Chem; 2010 Feb; 53(3):942-50. PubMed ID: 20043700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.